Qing-chun Fu

Consensus on the diagnosis and treatment of cholestatic liver diseases (2015, China)

Yue Zhang, Hong Tang, Lungen Lu, 2016, Journal of digestive diseases.

Diagnostic Performance of FibroTouch Ultrasound Attenuation Parameter and Liver Stiffness Measurement in Assessing Hepatic Steatosis and Fibrosis in Patients With Nonalcoholic Fatty Liver Disease

Lungen Lu, Jian-Gao Fan, Mingyi Xu, 2021, Clinical and translational gastroenterology.

Antiviral Therapy in Decompensated Cirrhosis due to Hepatitis B Virus

Chengwei Chen, Qing-chun Fu, 2011 .

Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial.

Jun Ye, Lungen Lu, Xia-qiu Zhou, 2003, World journal of gastroenterology.

CSH guidelines for the diagnosis and treatment of drug-induced liver injury

W. Cong, Lungen Lu, Chang-qing Yang, 2017, Hepatology International.

Clinical and molecular characterization of Wilson's disease in China: identification of 14 novel mutations

G. Zang, Q. Gong, Yue Han, 2011, BMC Medical Genetics.

[Magnesium isoglycyrrhizinate in the treatment of chronic liver diseases: a randomized, double-blind, multi-doses, active drug controlled, multi-center study].

Ying Sun, Lungen Lu, Xiong Cai, 2009, Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology.

Will Sofosbuvir/Ledipasvir (Harvoni) Be Cost-Effective and Affordable for Chinese Patients Infected with Hepatitis C Virus? An Economic Analysis Using Real-World Data

J. Chen, G. Lau, Lungen Lu, 2016, PloS one.

Risk assessment and prediction of severe or critical illness of COVID-19 in the elderly

Y. Ling, Z. Qian, Lin Zhang, 2020, medRxiv.